Niloufar Kavian
Tokyo Medical University(JP)Université Paris Cité(FR)Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale(FR)Saitama International Medical Center(JP)The University of Tokyo(JP)
Publications by Year
Research Areas
Systemic Sclerosis and Related Diseases, SARS-CoV-2 and COVID-19 Research, Mast cells and histamine, COVID-19 Clinical Research Studies, Cancer Treatment and Pharmacology
Most-Cited Works
- → ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection(2020)258 cited
- → Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the Mouse(2009)200 cited
- → Dimethyl fumarate, a two‐edged drug: Current status and future directions(2019)156 cited
- → SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection(2021)148 cited
- → Trained immunity modulates inflammation-induced fibrosis(2019)146 cited
- → Targeting the Cannabinoid Pathway Limits the Development of Fibrosis and Autoimmunity in a Mouse Model of Systemic Sclerosis(2010)118 cited